ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma.

Joseph M Tuscano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.